GSTM1 and anemia (phenotype): Typically, PRBCs are administered in the setting of severe anemia when immediate correction of Hb is required or ESA use is ineffective.24 Although it is unknown whether this was done deliberately to delay the administration of ESAs, this finding highlights the need for concessions based upon clinical judgment.